Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587834 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Gintuit(TM)for Oral Soft Tissue Regeneration
A Phase 3 study, sponsored by Organogenesis.
- Completed
- Registry status
- Phase 3
- Development phase
- 96
- Enrollment target
NCT00587834 is a Phase 3 study that has completed, run by Organogenesis. The registered enrollment target is 96 participants.
The verdict
NCT00587834, a Phase 3 study, has completed, sponsored by Organogenesis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 96 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate Gintuit as a safe and effective alternative to palatal tissue in the treatment of subjects (with recession-type defects) who have an insufficient zone of attached gingiva associated with at least two nonadjacent teeth.
Interventions
- DEVICE Gintuit
- OTHER Autologous palatal tissue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587834
The ClinicalTrials.gov registry entry for NCT00587834 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Organogenesis, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gintuit is the first listed.
NCT00587834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587834 about?
NCT00587834 is a clinical study titled "Safety and Efficacy of Gintuit(TM)for Oral Soft Tissue Regeneration". The purpose of this study is to evaluate Gintuit as a safe and effective alternative to palatal tissue in the treatment of subjects (with recession-type defects) who have an insufficient zone of attached gingiva associated with at least two nonadjacent teeth.
What is the current status of trial NCT00587834?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 96 participants. The study started on 2007-10. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00587834?
The interventions under investigation include: Gintuit (DEVICE), Autologous palatal tissue (OTHER).
Who is sponsoring clinical trial NCT00587834?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.